The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Pfizer is the #19 analyst pick.
Within the broader S&P 500, when components were ranked in terms of analyst favorites, PFE claims the #285 spot.
The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Pfizer is the #19 analyst pick.
Within the broader S&P 500, when components were ranked in terms of analyst favorites, PFE claims the #285 spot.
Looking at the stock price movement year to date, Pfizer is lower by about 4.9%.